PRGF-Endoret in Temporomandibular Joint Osteoarthritis – Giacomello et al. 2019
PRGF® Endoret injections for temporomandibular joint osteoarthritis treatment: a one-year follow-up
Authors: M. Giacomello, C. Mortellaro, C. Viganoni, A. Crimella, J. Fossati, and D. Lauritano
Source: Journal of Biological Regulators & Homeostatic Agents, 33(6 Suppl. 2), 215–222 (2019)
Study Design
Prospective clinical study involving 52 individuals. Three PRGF-Endoret injections at monthly intervals; pain at rest and maximum unassisted mouth opening were recorded up to one year after the last injection.
Results
The authors report improvements in pain at rest and mouth opening, which were maintained throughout the follow-up period.
Classification
The study does not have a parallel control group. The available PDF contains the table of contents and an article marked as a proof. The publication year in the article is 2019, which differs from the file name.
Document Language: English
Evaluates pain and mouth opening after PRGF-Endoret injections for temporomandibular joint osteoarthritis, with a one-year follow-up.